Biological Dynamics Expands Adoption of ExoVerita™ Pro Under Early Access Program

“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...

April 03, 2024 | Wednesday | News
Agilent Technologies and UC San Diego to Establish Center of Excellence in Cellular Intelligence

Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...

April 03, 2024 | Wednesday | News
Voydeya Approved as Add-On Therapy for Rare PNH Treatment in the US

Voydeya (danicopan) has been granted approval in the United States as an add-on therapy for the treatment of extravascular haemolysis (EVH) in adults diagn...

April 02, 2024 | Tuesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
Laborie Medical Technologies Corp. Invests in iO Urology's Revolutionary At-Home Uroflow Device for BPH Management

Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie) announced its investment in iO Urology, a vent...

April 01, 2024 | Monday | News
Exact Sciences and Mayo Clinic Report Promising Data on Non-Endoscopic Esophageal Cancer Screening Test

  Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, in collaboration with Mayo Clinic Compr...

March 28, 2024 | Thursday | News
Exothera Expands World-First Continuous-Batch RNA Manufacturing Solution to North America to Accelerate RNA Therapies

Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...

March 27, 2024 | Wednesday | News
Nucleus Genomics Launches to Bring Whole-Genome Sequencing to the Public

    Nucleus Genomics, a pioneering genetic testing and analysis company, announced the debut of its DNA analysis product, marking a significant...

March 26, 2024 | Tuesday | News
New Treatment Option for Prostate Cancer Shows Successful Outcomes

    Prostate cancer treatment traditionally involves radiation or surgery, both carrying risks of adverse effects like urinary incontinence and...

March 25, 2024 | Monday | News
Within3 and Array Announce Partnership to Set New Standards in Life Science Stakeholder Engagement

    Within3 and Array have announced a strategic partnership integrating synchronous and asynchronous insights management. This partnership is ...

March 20, 2024 | Wednesday | News
Lonza Strikes Deal with Roche: Acquires Genentech Facility in Vacaville for $1.2 Billion to Bolster Biologics Manufacturing Capacity

Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion in cash Vacaville (US) si...

March 20, 2024 | Wednesday | News
SCHOTT Pharma to Establish State-of-the-Art Facility in Wilson, North Carolina, Bolstering U.S. Pharmaceutical Supply Chain

   SCHOTT Pharma announces plans to solidify its footprint in the United States with the establishment of a cutting-edge facility in Wilson, Nor...

March 19, 2024 | Tuesday | News
Orchard Therapeutics Achieves Landmark FDA Approval for Lenmeldy™, Pioneering Gene Therapy for Early-onset Metachromatic Leukodystrophy

Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...

March 19, 2024 | Tuesday | News
Biotech Lobbying Powerhouse BIO Ends Association with WuXi AppTec Amid Security Crackdown

Biotechnology Innovation Organization (BIO), a leading lobbying group in Washington, D.C., announced its decision to sever ties with WuXi AppTec, a Chinese...

March 15, 2024 | Friday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close